
In vitro Validation of a Novel Disposable Remover to Remove Activated Leukocytes Generated During Cardiopulmonary Bypass:...
Introduction Cardiopulmonary bypass (CPB) during cardiac surgery strongly increases risk of postoperative morbidity and mortality, primarily because it can induce systemic inflammatory response syndrome (SIRS),1 which involves activation of leukocytes2,3 …